Santen Pharmaceutical Co., Ltd. (TYO: 4536)
Japan
· Delayed Price · Currency is JPY 1,561.00
+25.00 (1.63%)
Jan 20, 2025, 3:30 PM JST
Santen Pharmaceutical Revenue
Santen Pharmaceutical had revenue of 71.63B JPY in the quarter ending September 30, 2024, a decrease of -2.43%. This brings the company's revenue in the last twelve months to 302.56B, up 2.24% year-over-year. In the fiscal year ending March 31, 2024, Santen Pharmaceutical had annual revenue of 301.97B with 8.22% growth.
Revenue (ttm)
302.56B
Revenue Growth
+2.24%
P/S Ratio
1.84
Revenue / Employee
80.81M
Employees
3,744
Market Cap
532.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 301.97B | 22.93B | 8.22% |
| Mar 31, 2023 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2022 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2021 | 249.61B | 8.05B | 3.33% |
| Mar 31, 2020 | 241.56B | 7.53B | 3.22% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Otsuka Holdings | 2,269.56B |
| Terumo | 986.67B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |
Santen Pharmaceutical News
- 2 years ago - Santen Pharmaceutical Co., Ltd. (SNPHY) Management on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha